Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature

Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome: A Report of 10 Cases

(2014) Gianluigi Ardissino et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Defective Complement Inhibitory Function Predisposes to Renal Disease

(2012) Anuja Java et al.   Annual Review of Medicine

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

(2012) Julien Zuber et al.   Nature Reviews Nephrology

De novo Thrombotic Microangiopathy Induced by Cytomegalovirus Infection Leading to Renal Allograft Loss

(2010) Kristel De Keyzer et al.   AMERICAN JOURNAL OF NEPHROLOGY

Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

(2010) M. Noris et al.   Clinical Journal of the American Society of Nephrology

CMV PCR as a Diagnostic Tool for CMV Gastrointestinal Disease After Solid Organ Transplantation

(2010) Shellee A. Grim et al.   TRANSPLANTATION

Mutations in Proteins of the Alternative Pathway of Complement and the Pathogenesis of Atypical Hemolytic Uremic Syndrome

(2008) Cynthia Abarrategui-Garrido et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Complement Regulatory Genes and Hemolytic Uremic Syndromes

(2007) David Kavanagh et al.   Annual Review of Medicine